Status:
COMPLETED
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
Lead Sponsor:
Changhai Hospital
Conditions:
Esophageal Cancer
Eligibility:
All Genders
Brief Summary
Endoscopic submucosal dissection (ESD) is a minimally invasive alternative to esophagectomy for early esophageal squamous cell carcinoma (EESCC), The data of EESCC patients who received ESD or esophag...
Detailed Description
Endoscopic submucosal dissection (ESD) is a minimally invasive alternative to esophagectomy for early esophageal squamous cell carcinoma (EESCC).The aim of this study was to compare the efficacy and s...
Eligibility Criteria
Inclusion
- Mucosal or submucosal squamous cell carcinoma of the esophagus
- no lymph node involvement or distant metastasis on computed tomography (CT) or pathology;
Exclusion
- Tis premalignant lesions (high-grade intraepithelial neoplasia;HGIN)
- patients with neoadjuvant therapy
- patients combined with severe diseases of other organs
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT06060106
Start Date
January 1 2011
End Date
January 1 2023
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital, Naval Medical University
Shanghai, China